Connecticut Insurance Commissioner Katharine L. Wade moved to protect existing policyholders after HealthyCT learned June 30, 2016, it would have to pay CMS $13.4 million under the ACA Risk Adjustment program, which has been heavily criticized.
Days after CMS data showed that small insurers were battered by the risk adjustment formula for the second straight year, regulators in Connecticut moved to protect 40,000 policyholders by placing a co-op plan there under an order of supervision—and laid the blame squarely on the financial burden of the program created by the Affordable Care Act (ACA).
Connecticut Insurance Commissioner Katharine L. Wade today said that HealthyCT, a consumer oriented and operated plan, or co-op, would be barred from writing new business or renewing existing business immediately, following word June 30, 2016, that it must pay $13.4 million to CMS under the ACA’s Risk Adjustment Program.
“As a result, it became evident that this risk adjustment mandate would put the company under significant financial strain,” Wade said in a statement. “This order of supervision provides for an orderly run-off of the company’s claim payment under close regulatory oversight.”
Risk Adjustment is a provision of the ACA designed to keep insurers from steering clear of consumers with pre-existing medical conditions. Each year, it requires those who have lower-risk enrollees to transfer funds to those with higher risk clients. But multiple critics say it unduly disadvantages newer insurers, especially co-ops, that have lower rates and less experience in the market. Only 10 co-ops remained as of last week, according to CMS data.
On June 15, 2016, a Maryland co-op, Evergreen Health, sued CMS over the program, and on Friday New York regulators called for immediate changes. CMS has said it plans to rework the program by 2018, but many state regulators say that will be too late for regional insurers that are essential to create healthy, competitive insurance markets.
In New York State, Department of Financial Services Superintendent Maria Vullo sent a letter Friday that she was "very concerned" that smaller, newer insurers will pay millions of dollars into the pool because they appear to have healthier clients, largely because they haven't generated sufficient patient records yet.
The failure of the Connecticut’s co-op will surely bring howls that yet another of the 23 original co-ops has gone under. In March, an analysis in the Fiscal Times found that despite start-up loans and grants, most did not achieve enrollment projections and others failed due to cuts in risk corridor funding. But burdensome regulations hampered success, too—another analysis noted that the co-ops were barred from hiring people who had ever served in senior leadership at insurance companies—in other words, the kind of people with the experience needed to guarantee success.
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More